| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |